Dive Into the New Age of Accelerated Diagnostics & Biologics
Our Technology
Highly Diverse, verified Precision Nanobody Libraries
We have created well-designed, highly diverse libraries to ensure unparalleled creation of thousands to billions of specific variants with multiple germline scaffolds and expanded epitope coverage for any target of interest.
Our Naive nanobody library (VHH) were used to successfully identify hits against SARS-CoV2, Omicron and Delta variants
NANOdx Discovery Platform
Rapid Yeast display, best-in-class platform using off-the-shelf superior quality, target-focused synthetic libraries, giving a multifaceted approach to discovery project. The NanoDx discovery platform identify high-quality leads against your target of interest in only 6-8 weeks long discovery cycle
Nanobody cellular Optimization platform
Optimize lead nanobody for greater potency and developability in in-vitro and cellular assays.
Flexible vertical for analytical and process development
Upstream and downstream process development including high-throughput protein expression, host selection, clone selection, expression of Nanobodies, Transient expression in Mammalian cells and stable pool generation.
Analytical development- Target primary and secondary order structure identification, heterogeneity variant detection, In-silico binding kinetic studies and Potency validations
